Digital technology brings
era of preventive healthcare
To the future where no one gets sick.
To the society where everyone can live their own way.
We listen to the "voice of life."
We will show you the “current” and “future” health status and
disease risk in an easy-to-understand manner and
propose improvement measures that suit each individual.
We will make a society stress-free and
where everyone can live in their own way.
There are many diseases, such as heart disease and diabetes, where lifestyle is a factor,
but actually changing habits and behaviors is not so easy to do.
In addition, protein is an important component in the human body, and
since its ratio in the body changes depending on lifestyle, measuring protein is a good way to understand the current state of health.
On the other hand, genes that do not change throughout life can be used to estimate tendencies but not the current state.
We utilize blood protein measurement technology and data analysis and
simulation technology to visualize the current state of health and disease risks in an easy-to-understand way, and
support behavioral changes by proposing improvements and simulating the results to suit each individual.
In addition, we develop and provide services to support health in cooperation with companies and organizations.
Utilizing SomaScan®, a technology that measures approximately 7,000 different proteins from serum, plasma and urine
NEC Group’s ICT
and AI technology
Technology to measure about 7,000 different proteins is available for a wide range of researches and developments at research institutes and academia. If you are interested in the technology, please contact us here.
FonesVisuas predicts the suspicion and risk of contracting all target diseases in the future in a single measurement. We also visualize (estimate) your current health condition and make proposals to improve health to support your future and health.
Development of health support service
We improve the added value of services provided by companies and organizations, and collaborate to develop and provide new services.
※ FonesVisuas is available only at medical institutions in consultation with medical doctors of medical institutions. Please contact a medical institution if you would like to use the service.
※ The tests conducted with this service cannot be used for diagnostic or medical directly. Please use the test results to improve your daily lifestyle habits. Please consult with a medical institution about concern about your health status or medical treatment for disease.
- Company name
- FonesLife Corporation
- April 1, 2020
- Head Office
- 3-8-3, Nihonbashi-Honcho, Chuo-Ku, Tokyo 103-0023, Japan
- Paid-in Capital
- 325,000,000 yen
- Representative Director
Chief Executive Officer
- Naoto Egawa
- Director（Executive Vice President, NEC Solution Innovators, Ltd.）
- Masahiko Ishii
- Director（Senior Vice President, NEC Solution Innovators, Ltd.）
- Shigeru Matsuo
- Director（CEO, SomaLogic Operating Co., Inc.）
- Roy Smythe
- Auditor（Corporate Finance and Comptroller Division Senior Manager, NEC Solution Innovators, Ltd.）
- Eiki Satou
- Chief Technology Officer
- Iwao Waga
- Representative Director
- Number of Employees
- 30 (As of Jun.1,2022)
- Laboratory Name
- FonesLife Clinical Laboratory Tokyo Bay
FonesLife Proteomics Laboratory
- MITSUI LINK-Lab SHINKIBA 1
2-3-8, Shinkiba, Koto-ku, Tokyo 136-0082, Japan
- Registered Clinical Laboratory based on Article 20(3)(i) of Act on Clinical Laboratory Technicians
- Blood Serum Seperation
- Registration No.※
- Registration Date※
- August 19, 2021
*Profile, Registered Clinical Test, Registration No., and Registration Date are the only information for FonesLife Clinical Laboratory Tokyo Bay.